Antibiotic-resistant bacterial infections arising from acquired resistance and/or through
biofilm formation necessitate the development of innovative 'outside of the box'therapeutics …

The wide spread of antibiotic resistance has been alarming in recent years and poses a
serious global hazard to public health as it leads to millions of deaths all over the world. The …

The clinical applications of nanotechnology are emerging as widely popular, particularly as
a potential treatment approach for infectious diseases. Diseases associated with multiple …

Respiratory diseases gather a wide range of disorders which are generally difficult to treat,
partly due to a poor delivery of drugs to the lung with adequate dose and minimum side …

Antimicrobial resistance is a major and growing global problem and new approaches to
combat infections caused by antibiotic resistant bacterial strains are needed. In recent years …

Lung diseases, including COVID-19 and lung cancers, is a huge threat to human health.
However, for the treatment and diagnosis of various lung diseases, such as pneumonia …

Staphylococcus aureus (S. aureus) is able to hide within host cells to escape immune
clearance and antibiotic action, causing life‐threatening infections. To boost the therapeutic …

Noble bimetallic and trimetallic nanoparticles (NBT-NPs) have superior biomedical
applications as compared to their monometallic counterparts. The performance of these …

Rapid emergence of aggressive, multidrug-resistant Mycobacteria strain represents the
main cause of the current antimycobacterial-drug crisis and status of tuberculosis (TB) as a …

Antibiotic resistance in bacteria is a major problem worldwide that costs 55 billion USD
annually for extended hospitalization, resource utilization, and additional treatment …